** Shares of medical device maker GE Healthcare Technologies GEHC.O rise 3% to $69.03
** China's government is considering suspending its 125% tariff on some U.S imports, including medical equipment and some industrial chemicals like ethane, according to a Bloomberg News report
** Brokerage J.P. Morgan says it will benefit players like GEHC since hospitals in China still rely on advanced medical equipment, including large capital like surgical robots, MRI and ultrasound machines, for which domestic competition is lagging
** GEHC has previously said it expects its full-year profit to be hit due to U.S. tariffs imposed on products from China
** The company's China sales declined 15% in 2024, and it expects sales in the region to remain under pressure in the near term
** Thirteen out of 19 brokerages rate the stock "buy" or higher, 5 rate "hold", 1 rate "sell" and their median PT is $96.36 as per data compiled by LSEG
** Including session moves, GEHC stock down 11.1% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。